Publication | Closed Access

pH-responsive nanomedicine co-encapsulated with Erlotinib and chlorin e6 can enable effective treatment of triple negative breast cancer via reprogramming tumor vasculature

NanomedicineNanotherapeuticsEngineeringTherapeutic NanomaterialsChlorin E6Effective TreatmentBreast CancerNano-drug DeliveryTumor TargetingBiomedical EngineeringMedicineRadiation OncologyTumor MicroenvironmentTumor Vasculature